Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 16, 2020 - Issue
Submit an article Journal homepage
295
Views
19
CrossRef citations to date
0
Altmetric
Review

Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date

Jean Kim1 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA;2 Department of Medicine: Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7895-7193
ORCID Icon &
Robert Naclerio1 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Pages 31-37 | Published online: 23 Jan 2020

Figures & data

Figure 1 Dupilumab mechanism of action in Type 2 inflammation of chronic rhinosinusitis with nasal polyposis.

Notes: X=dupilumab. Y= IL4Rα.

Figure 1 Dupilumab mechanism of action in Type 2 inflammation of chronic rhinosinusitis with nasal polyposis.Notes: X=dupilumab. Y= IL4Rα.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.